secwatch / observer
8-K filed March 25, 2024, 7:59 PM ET ticker DUOT CIK 0001396536
other material confidence high sentiment neutral materiality 0.60

Duos Technologies raises $2.625M via Series D and Series E convertible preferred stock

DUOS TECHNOLOGIES GROUP, INC.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

DUOS TECHNOLOGIES GROUP, INC. entered into Series D Purchase Agreement with certain accredited investors valued at proceeds of $500,000 (effective 2024-03-22).

Action
entry
Agreement
equity purchase
Counterparty
certain accredited investors
Value
proceeds of $500,000
Effective
2024-03-22
Exact text from the filing
Pursuant to one agreement (the “Series D Purchase Agreement”), the Company issued an aggregate of 500 shares of Series D Convertible Preferred Stock (the “Series D Preferred Stock”) and the Company received proceeds of $500,000.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

DUOS TECHNOLOGIES GROUP, INC. entered into Series E Purchase Agreement with certain accredited investors valued at proceeds of $2,125,002 (effective 2024-03-22).

Action
entry
Agreement
equity purchase
Counterparty
certain accredited investors
Value
proceeds of $2,125,002
Effective
2024-03-22
Exact text from the filing
Pursuant to the other agreement (the "Series E Purchase Agreement" and, collectively with the Series D Purchase Agreement, the “Purchase Agreements”), the Company issued an aggregate of 2,125 shares of Series E Convertible Preferred Stock (the “Series E Preferred Stock”) and the Company received proceeds of $2,125,002.
View on SEC.gov

545 material agreements filed in the last 30 days. Browse all material agreements →

DUOS TECHNOLOGIES GROUP, INC. filing history →

Source: SEC EDGAR
accession 0001079973-24-000411
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.